PALIVIZUMAB

UNII:	DQ448MW7KS
Formula:
Preferred Substance Name:	PALIVIZUMAB

188039-54-5
IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS PROTEIN F)(HUMAN-MOUSE MONOCLONAL MEDI-493 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-493 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS PROTEIN F)(HUMAN-MOUSE MONOCLONAL MEDI-493 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-493 .KAPPA.-CHAIN, DIMER
PALIVIZUMAB [EMA EPAR]
PALIVIZUMAB [INN]
PALIVIZUMAB [JAN]
PALIVIZUMAB [MART.]
PALIVIZUMAB [MI]
PALIVIZUMAB [PURPLE BOOK CDER]
PALIVIZUMAB [USAN]
PALIVIZUMAB [VANDF]
PALIVIZUMAB [WHO-DD]
SYNAGIS

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PALIVIZUMAB

Synonyms and Mappings

Resources